WO2003080037A2 - Verwendung von ltb4 antagonisten in der tiermedizin - Google Patents
Verwendung von ltb4 antagonisten in der tiermedizin Download PDFInfo
- Publication number
- WO2003080037A2 WO2003080037A2 PCT/EP2003/003021 EP0303021W WO03080037A2 WO 2003080037 A2 WO2003080037 A2 WO 2003080037A2 EP 0303021 W EP0303021 W EP 0303021W WO 03080037 A2 WO03080037 A2 WO 03080037A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- group
- phenyl
- formula
- alkoxy
- Prior art date
Links
- 0 CCC(I)I(=CC(C)(C)C=C(*C(C=C1)=CC=CC1(C)C(CC)=CC)/C=C1)=C[C@@]1(C)N Chemical compound CCC(I)I(=CC(C)(C)C=C(*C(C=C1)=CC=CC1(C)C(CC)=CC)/C=C1)=C[C@@]1(C)N 0.000 description 3
- SBVYURPQULDJTI-UHFFFAOYSA-N CCOC(/N=C(/c(cc1)ccc1OCc1cc(COc2ccc(C(C)(C)c(cc3)ccc3O)cc2)ccc1)\N)=O Chemical compound CCOC(/N=C(/c(cc1)ccc1OCc1cc(COc2ccc(C(C)(C)c(cc3)ccc3O)cc2)ccc1)\N)=O SBVYURPQULDJTI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Definitions
- Mimetic or at least one steroid are Mimetic or at least one steroid.
- Phenylene group stands; or A is a group of the formula
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002480032A CA2480032A1 (en) | 2002-03-26 | 2003-03-24 | Use of ltb4 antagonists in veterinary medicine |
JP2003577866A JP2005529085A (ja) | 2002-03-26 | 2003-03-24 | 動物薬におけるltb4拮抗薬の使用 |
EP03708263A EP1490042A2 (de) | 2002-03-26 | 2003-03-24 | Verwendung von ltb4 antagonisten in der tiermedizin |
AU2003212375A AU2003212375A1 (en) | 2002-03-26 | 2003-03-24 | Use of ltb4 antagonists in veterinary medicine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10213350A DE10213350A1 (de) | 2002-03-26 | 2002-03-26 | Verwendung von LTB¶4¶Antagonisten in der Tiermedizin |
DE10213350.6 | 2002-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003080037A2 true WO2003080037A2 (de) | 2003-10-02 |
WO2003080037A3 WO2003080037A3 (de) | 2004-06-10 |
Family
ID=28050833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/003021 WO2003080037A2 (de) | 2002-03-26 | 2003-03-24 | Verwendung von ltb4 antagonisten in der tiermedizin |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1490042A2 (de) |
JP (1) | JP2005529085A (de) |
AR (1) | AR039141A1 (de) |
AU (1) | AU2003212375A1 (de) |
CA (1) | CA2480032A1 (de) |
DE (1) | DE10213350A1 (de) |
PE (1) | PE20030947A1 (de) |
TW (1) | TW200407109A (de) |
UY (1) | UY27731A1 (de) |
WO (1) | WO2003080037A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200199168A1 (en) | 2017-05-12 | 2020-06-25 | Riken | Class a gpcr-binding compound modifier |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0544488A2 (de) * | 1991-11-25 | 1993-06-02 | Eli Lilly And Company | Substituierte Phenylphenol-Leukotrienantagonisten |
US5246965A (en) * | 1991-06-11 | 1993-09-21 | Ciba-Geigy | Arylethers, their manufacture and methods of treatment |
WO1998011062A1 (de) * | 1996-09-10 | 1998-03-19 | Boehringer Ingelheim Pharma Kg | Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung |
US6291531B1 (en) * | 1999-10-07 | 2001-09-18 | Boehringer Ingelheim Pharma Kg | LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition |
-
2002
- 2002-03-26 DE DE10213350A patent/DE10213350A1/de not_active Withdrawn
-
2003
- 2003-03-24 UY UY27731A patent/UY27731A1/es not_active Application Discontinuation
- 2003-03-24 WO PCT/EP2003/003021 patent/WO2003080037A2/de not_active Application Discontinuation
- 2003-03-24 TW TW092106507A patent/TW200407109A/zh unknown
- 2003-03-24 AU AU2003212375A patent/AU2003212375A1/en not_active Abandoned
- 2003-03-24 JP JP2003577866A patent/JP2005529085A/ja active Pending
- 2003-03-24 CA CA002480032A patent/CA2480032A1/en not_active Abandoned
- 2003-03-24 PE PE2003000289A patent/PE20030947A1/es not_active Application Discontinuation
- 2003-03-24 EP EP03708263A patent/EP1490042A2/de not_active Withdrawn
- 2003-03-26 AR ARP030101046A patent/AR039141A1/es not_active Suspension/Interruption
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246965A (en) * | 1991-06-11 | 1993-09-21 | Ciba-Geigy | Arylethers, their manufacture and methods of treatment |
EP0544488A2 (de) * | 1991-11-25 | 1993-06-02 | Eli Lilly And Company | Substituierte Phenylphenol-Leukotrienantagonisten |
WO1998011062A1 (de) * | 1996-09-10 | 1998-03-19 | Boehringer Ingelheim Pharma Kg | Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung |
US6291531B1 (en) * | 1999-10-07 | 2001-09-18 | Boehringer Ingelheim Pharma Kg | LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition |
Non-Patent Citations (1)
Title |
---|
FINK MITCHELL P ET AL: "A novel leukotriene B-4-receptor antagonist in endotoxin shock: A prospective, controlled trial in a porcine model." CRITICAL CARE MEDICINE, Bd. 21, Nr. 12, 1993, Seiten 1825-1837, XP009011647 ISSN: 0090-3493 * |
Also Published As
Publication number | Publication date |
---|---|
AR039141A1 (es) | 2005-02-09 |
PE20030947A1 (es) | 2004-01-13 |
UY27731A1 (es) | 2003-10-31 |
TW200407109A (en) | 2004-05-16 |
DE10213350A1 (de) | 2003-10-16 |
CA2480032A1 (en) | 2003-10-02 |
EP1490042A2 (de) | 2004-12-29 |
AU2003212375A1 (en) | 2003-10-08 |
JP2005529085A (ja) | 2005-09-29 |
WO2003080037A3 (de) | 2004-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60026144T2 (de) | Benzamidformulierung mit histon-deacetylase-inhibitoraktivität | |
DE60211937T2 (de) | Verwendung von flibanserin bei der behandung von störungen des sexuellen verlangens | |
EP2269647A2 (de) | Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika | |
DE102004011512A1 (de) | Pharmazeutische Zubereitung enthaltend Pimobendan | |
EP2477660A1 (de) | Pharmazeutische zusammensetzung mit den wirkstoffen metformin und sitagliptin oder vildagliptin | |
DE60307258T2 (de) | Salze von Tolterodin | |
EP1812002B1 (de) | Behandlung von mastitis | |
DE60101559T2 (de) | Benutzung von comt-inhibitoren als analgetika | |
EP1682144B1 (de) | Geschmacksstoffhaltige arzneimittelformulierungen mit verbesserten pharmazeutischen eigenschaften | |
EP2432452B1 (de) | Pharmazeutische telmisartan-trinklösung | |
DE60030654T2 (de) | Verwendung von Lasofoxifen | |
DE2360332C2 (de) | Die Verwendung von 1-Carnitin oder einem 1-Carnitinderivat oder eines Salzes davon bei der Behandlung spezieller Lungenkrankheiten | |
DE102007052070A1 (de) | Candesartancilexetil | |
EP2934490B1 (de) | Tabletten mit verbesserter akzeptanz und guter lagerstabilität | |
DE69907387T2 (de) | Verwendung von Hydantoin-Derivaten zur Herstellung eines Medikaments zur Behandlung von refraktärer Vasculitis. | |
DE69127285T2 (de) | Verwendung von verbindungen zur behandlung von altersbedingtem gedächtnisschwund und anderen kognitiven störungen | |
EP1490042A2 (de) | Verwendung von ltb4 antagonisten in der tiermedizin | |
DE19815411A1 (de) | Thermogenese stimulierend wirksame Arzneimittel | |
DE3528481A1 (de) | Neues pharmazeutisches praeparat | |
DE2605243A1 (de) | Pyrazolessigsaeurehaltiges arzneimittel | |
US20030225004A1 (en) | Use of LTB4 antagonists in veterinary medicine | |
DE69302250T2 (de) | Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia | |
DE60311134T2 (de) | Oromukosale formulierung und herstellungsverfahren dafür | |
DE2823268A1 (de) | Blutdrucksenkendes mittel | |
DE2551591A1 (de) | 4-(4-diphenylyl)-butylamine und pharmazeutische zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003708263 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2480032 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003577866 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003708263 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003708263 Country of ref document: EP |